Post on 19-Mar-2016
description
transcript
Changing Lives through Science and Advocacy
Meet The Sabin Vaccine Institute
The Sabin Vaccine Institute is a leading nonprofit organization made up of scientists, researchers and advocates dedicated to improving the health of the world’s poorest citizens.
What We Do
Our mission is to reduce needless
suffering from vaccine-preventable
and neglected tropical diseases
by developing new vaccines,
advocating for increased access
to existing vaccines and promoting
expanded access to affordable
medical treatments.
More than 20 Years of Success
Since 1993, Sabin Vaccine Institute
(Sabin) has been at the forefront of
the global effort to reduce the burden
of vaccine-preventable diseases and
diseases that perpetuate poverty.
Our approach relies on scientific
innovation, coupled with advocacy,
communications and partnership
cultivation. From launching new
clinical trials, to leading scores of
high-level advocacy meetings, to
kick-starting public awareness
of global disease burdens, Sabin
advances the important mission of
improved global health.
Sabin Vaccine Institute was founded
to honor the legacy of Dr. Albert B.
Sabin, the developer of the oral polio
vaccine that has successfully brought
the disease to the brink of eradication.
Developing New Vaccines
Vaccines are among the most
economical and effective medical
technologies available today. Yet,
there is an urgent need for new and
more effective vaccines to fight
diseases that primarily impact those
in poverty.
Product Development Partnerships
(PDPs) provide a valuable model for
vaccine development by convening
public, private and academic partners
who each contribute something
different – from technical expertise,
to manufacturing capabilities, to
funding – to the development and
production of safe, effective vaccines.
The Sabin Vaccine Institute Product
Development Partnership (Sabin
PDP) is a leader in the field, with more
than a decade of experience in
vaccine research and development
for neglected tropical diseases that
infect hundreds of millions of people
in poor and underserved communities.
The Sabin PDP is the only partner-
ship advancing vaccine candidates
to prevent human hookworm – an
intestinal worm infection that affects
more than 700 million people around
the world. In addition, the Sabin PDP
is spearheading major vaccine research
and development projects targeting
diseases such as schistosomiasis,
severe acute respiratory syndrome
(SARS), Chagas disease, leishmaniasis,
ascariasis and trichuriasis.
Learn about our vaccine development program and the Sabin PDP partners at www.sabin.org/pdp
Promoting Immunization
Every year, vaccine-preventable
diseases cause 1.5 million child deaths
and countless cases of illness. Sabin
is dedicated to reducing the burden
and impact of vaccine-preventable
diseases, including typhoid and
paratyphoid fever, pneumococcal
disease, meningococcal disease,
human papillomavirus (HPV),
pertussis, polio, measles, rotavirus
and rubella. We also lay the ground-
work for introducing new vaccines
in endemic regions for diseases
such as dengue fever.
Technological advancements in
vaccine development are spawning
a new generation of increasingly
powerful vaccines, including
therapeutic vaccines, which have
the potential to save millions of lives
and alleviate unnecessary illness
every year. But, they must be made
available to everyone.
Education Sabin educates leaders from national
governments, the private sector,
media and civil society organizations
on the value of immunization and
encourages collaboration among all
development partners on vaccine
issues. Each year, Sabin coordinates
symposia, conferences and peer
exchanges on immunization in order
to improve global awareness, access,
policy and action.
Vaccine-preventable diseases cause 1.5 million child deaths and countless cases of illness every year.
This can and must change.
Learn more about our our work in advocacy and education at www.sabin.org/VAE
Advocacy Sabin leads a host of immunization
initiatives, including:
∞ Coalition against Typhoid
(CaT) Secretariat
∞ Dengue Vaccine Initiative
(DVI)
∞ International Association
of Immunization
Managers (IAIM)
∞ Pneumococcal Awareness
Council of Experts (PACE)
∞ ProVac International
Working Group (IWG)
∞ ROTA Council
∞ Sustainable Immunization
Financing (SIF)
Together, these initiatives help
countries make informed vaccine
policy decisions, access new vaccines
and expand disease control efforts.
We are working to expand
access to vaccines for:
∞ Typhoid
∞ Paratyphoid Fever
∞ Pneumococcal Disease
∞ Meningococcal Disease
∞ Human Papillomavirus
(HPV)
∞ Pertussis
∞ Polio
∞ Measles
∞ Rotavirus
∞ Rubella
Controlling and Eliminating Neglected Tropical Diseases
One in six people worldwide,
including more than half a billion
children, are infected with neglected
tropical diseases (NTDs). The Global
Network for Neglected Tropical
Diseases, a Sabin initiative, is working
to raise the awareness, political
will, and funding necessary to control
and eliminate the seven most
common NTDs.
These diseases cause blindness,
malnutrition and anemia, and
they create serious health risks
for women of reproductive age.
NTDs contribute to poverty
by reducing school attendance
among children and worker
productivity among adults.
The solution is within reach! For only 50 cents per person
annually, a packet of pills – donated
by the pharmaceutical companies –
can be administered to treat all seven
diseases. We work with our partners to
raise awareness of neglected tropical
diseases and help them deliver these
solutions to suffering communities.
Treatment Costs
50 Cents Per Person
Per Year
Learn more about the Global Network at www.globalnetwork.org
Seven NTDs∞ Hookworm ∞ Whipworm (ascariasis)∞ Roundworm (trichuriasis)∞ Elephantiasis
(lymphatic filariasis)∞ River Blindness
(onchocerciasis)∞ Snail Fever
(schistosomiasis)∞ Trachoma
50 ¢
What Your Contribution Means
Your support will allow us to meet
major milestones including:
• Bringingnewvaccine
candidatesthroughclinical
trials,licensureandmanufacture,
totacklediseasessuchashook-
worm,schistosomiasis,SARS,
Chagasdisease,leishmaniasis,
ascariasisandtrichuriasis.
• Reducingtheglobalprevalence
ofvaccine-preventablediseases
thatcausemorethan1.5million
childdeathseachyear
• Controllingandeliminatingthe
sevenmostcommonneglected
tropicaldiseasesthatinfectone
insixpeopleworldwideby2020
We believe that people everywhere have a right to good health that will empower them to lead successful lives. You can help us realize our vision of a world free of diseases of poverty.
Please support our mission today.
Web www.sabin.org/donateEmail donate@sabin.org
We provide strong, responsible
stewardship of donor funding.
Sabin has received Charity
Navigator’s highest four-star rating
since 2008, placing us in the top
four percent of evaluated charities, a
ranking that reflects our transparency,
accountability and efficiency.
Sabin Vaccine Institute is
a 501(c)(3) organization.
Our Tax ID number is
06-1389829.
Sabin Vaccine Institute2000 Pennsylvania Avenue, NWSuite 7100Washington, DC 20006
Phone: +1 (202) 842-5025Web: www.sabin.orgEmail: info@sabin.org
@sabinvaccine
facebook.com/sabinvaccine
Board of Trustees
Morton P. Hyman
Chairman
Founder and CEO of
MPH Enterprises, LLC
Allan L. Goldstein, Ph.D.
Professor and Emeritus Chairman
Department of Biochemistry &
Molecular Biology, The George
Washington University School
of Medicine
Rt. Hon. Baroness Helene
Hayman, GBE
Immediate Past Lord Speaker
of the House of Lords, United
Kingdom Parliament
Axel Hoos, M.D., Ph.D.
Vice President, Oncology R&D,
GlaxoSmithKline Pharmaceuticals
Michael H. Posner
Professor of Business and Society,
NYU Stern School of Business
Kevin L. Reilly
Former Chairman of the Board,
VaxGen, Inc.
Gary Rosenthal
Partner in the Sterling Group, L.P.
Immediate Past Chairman of
the Board of Trustees, Texas
Children’s Hospital
Philip K. Russell, M.D.
Past Chairman
Major General, U.S. Army Medical
Corps (Ret.)
Marc Shapiro
Non-Executive Chairman,
Chase Bank of Texas
Immediate Past Chairman of the
Board of Trustees, Baylor College
of Medicine
Peter L. Thoren
Executive Vice President,
Access Industries, Inc.
Michael E. Whitham
Secretary and Treasurer
Founding partner, Whitham,
Curtis, Christofferson & Cook
Heloisa Sabin
Honorary Trustee
Executive Leadership
Michael W. Marine,
Ambassador (Ret.)
Chief Executive Officer
Peter J. Hotez, M.D., Ph.D.
President
Director, Sabin Vaccine Institute
and Texas Children’s Hospital
Center for Vaccine Development
Ciro de Quadros, M.D., M.P.H.
Executive Vice President
Director, Vaccine Advocacy and
Education
Neeraj Mistry, M.D., M.P.H.
Managing Director
Global Network for Neglected
Tropical Diseases
Brian Davis, C.P.A.
Chief Operating Officer
Larry Ellingsworth, Ph.D.
Vice President
Deputy Director, Sabin PDP